MarketKevin Sabet
Company Profile

Kevin Sabet

Kevin Abraham Sabet is an American drug policy scholar, who served as a White House Office of National Drug Control Policy advisor. He is the only person appointed to that office in both Republican and Democratic administrations. Sabet has previously been an assistant professor adjunct at Yale University Medical School's Institution for Social and Policy Studies, and a columnist at Newsweek.

Education
Sabet is a graduate of the University of California, Berkeley and Oxford University, where he received his Doctorate in social policy as a Marshall Scholar. Critics have noted that despite his affiliation with Yale Medical School, Sabet does not hold a medical degree or medical training. His academic background is in social policy and political science, which some legalization advocates argue undermines his credibility when making health-related claims about cannabis. ==Drug policy advocacy==
Drug policy advocacy
Sabet began his activism as a teenager, campaigning against the abolition of after-school programs sought by the libertarian-leaning Orange County school board. During his freshman year at the University of California, Berkeley, Sabet started Citizens for a Drug-Free Berkeley and worked to educate his peers on the "wave of destruction" that comes with club drugs, including MDMA. He has testified for the US Congress, Canadian Parliament, UK Parliament, Italian Parliament, and UN bodies multiple times. He has been an invited witness at the U.S. Senate on marijuana issues generally, and cannabidiol. Sabet has written on the need for prevention, treatment, and enforcement to guide drug policy, although he has also argued for abolishing severe sentencing guidelines, like mandatory minimum laws. His articles have been published in newspapers, such as The Washington Post and The New York Times. He has argued for removing criminal penalties for low-level marijuana use, though steadfastly opposes legalization while supporting continued civil penalties for use, along with mandated treatment. He supports charges for manufacturing or selling large amounts of cannabis. Through the work of SAM, Sabet has been an active voice in successful campaigns to stop marijuana legalization initiatives in Ohio (2015), and legislative initiatives in New Jersey, New York, Connecticut, and other states. In New Jersey, Sabet and SAM have partnered with senators, including Senator Ronald Rice, pastors, community organizers, and other public health and safety advocates to resist Governor Phil Murphy's push to commercialize marijuana in the state. This resistance was ultimately unsuccessful after Question 1 was approved by voters in November 2020 and enacted the following February. In the 2018 legislative sessions, Sabet and SAM were active with coalitions in successful efforts to defeat marijuana legalization and commercialization bills in Illinois, New Hampshire, and Vermont. While Vermont decriminalized marijuana possession in 2013 and allowed for personal use and "home-grow" in 2018, Sabet and SAM have worked with partners to defeat outright commercialization such as seen in Colorado, California, and Washington (Vermont later legalized commercial marijuana sales in October 2020 despite SAM's opposition). Prior to SAM's founding, Sabet wrote op-eds and spoke across the United States. Some say Sabet is arguably the most influential person in the movement against cannabis legalization in the United States. Sabet has also organized coalition letters to various administrations regarding the central role of Office of National Drug Control Policy in policy making, and produced a video for Biden transition advisors. Smart Approaches to Marijuana helped support efforts to roll back supposed cannabis industry influence in Colorado, tightening current medical and recreational laws. SAM has campaigned against marijuana legalization ballot initiatives in multiple states with mixed results. The organization claimed victory in Ohio (2015), though Ohio later approved legalization in 2023. SAM invested heavily in Arizona's 2016 campaign, where Proposition 205 was defeated; however, Arizona voters approved legalization in 2020. In Michigan (2018), SAM reportedly invested approximately $1.7 million opposing Proposal 1, which nonetheless passed. New Jersey voters approved legalization in 2020 despite SAM's opposition. ==Funding and Transparency==
Funding and Transparency
SAM's funding sources have been a subject of controversy. According to New York State lobbying records, SAM spent $84,795 lobbying against legalization in the first half of 2019. The organization reportedly sought to keep its donor list confidential, claiming donors would face harassment; however, the New York State ethics commission denied this request. Some critics allege connections between SAM's funding and federal drug enforcement grants, as well as pharmaceutical industry interests. Sabet and SAM have denied that their positions are influenced by industry funding. ==Books and writings==
Books and writings
His new book, One Nation Under the Influence: America’s Deadly Drug Habit and How We Can Overcome It, "offers effective solutions to the drug crisis, taking readers all over the country—from the streets of San Francisco and New York to the Southern Border and even Canada to show a new way forward." It has received significant advance praise. David Sheff has said, "Kevin Sabet has dedicated his life to understanding America’s drug problem and finding solutions. One Nation Under the Influence is the result: a groundbreaking account that’s sorely needed at a time when we’re losing so many of our loved ones to overdose and addiction.” Former three-time drug czar Robert DuPont calls the book Sabet's "magnum opus--the book he has always threatened to write." Keith Humphreys called it "a wide-ranging analysis of our country’s drug problem by one of its most influential drug policy advocates.” His 2021 book'', Smokescreen: What the Marijuana Industry Doesn't Want You to Know,'' was released April 20, 2021. His first book, Reefer Sanity: Seven Great Myths About Marijuana, is now in its second edition. Sabet also co-edited Contemporary Health Issues on Marijuana, published by Oxford, which was highlighted by Jane Brody in The New York Times. Critics, including drug policy reform advocates and some medical professionals in states with legal cannabis programs, argue that Sabet's positions ignore evidence from medical cannabis programs operating in over 38 states and continue to criminalize cannabis users through mandated treatment and civil penalties. ==References==
tickerdossier.comtickerdossier.substack.com